跳至主要内容
临床试验/NCT02785458
NCT02785458已完成不适用

Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

Northwestern University2 个研究点 分布在 1 个国家目标入组 1,005 人开始时间: 2017年6月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,005
试验地点
2
主要终点
Medication Knowledge (0-100)

研究概览

简要总结

This study evaluates the effectiveness of an electronic health record based educational intervention (the EMC2 strategy) to improve patient understanding and use of higher-risk medications. Half of the participants will receive the intervention, while the other half will receive the usual amount of information (usual care).

详细描述

Research has repeatedly demonstrated that individuals lack essential information on how to safely take prescribed (Rx) medications. A risk communication and surveillance strategy is needed in primary care to ensure that patients are adequately informed about medication risks and are taking prescribed regimens safely.

The investigators devised an Electronic health record-based Medication Complete Communication (EMC2) Strategy that leverages electronic health record (EHR) and interactive voice response (IVR) technologies to:

  1. prompt and guide provider counseling,
  2. automate the delivery of Medication Guides at prescribing,
  3. follow patients post-visit to confirm prescription understanding and use, and
  4. deliver a care alert back to providers to inform them of any potential harms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 21 and older
  • English or spanish speaking
  • Primarily responsible for administering own medications
  • New prescription of one of 66 study medications on day of recruitment
  • Has a personal mobile or land line phone

排除标准

  • Severe, uncorrectable vision
  • Hearing or cognitive impairments

结局指标

主要结局

Medication Knowledge (0-100)

时间窗: Baseline to 3 Months post baseline

Adjusted Least-square means of Medication Knowledge are calculated based on patient's ability to identify each medication's purpose and side effects, risks, warnings and benefits using general linear mixed models, specifying the identity link (PROC GLIMMIX). Treatment assignment by time is the independent variable of interest and modeled as a fixed effect, and clinic as a random effect, with additional subject statement to model correlations with patient. Confounding variables, such as age, preferred language, race, education, health status, number of chronic diseases, drug class, and health literacy (Newest Vital Sign) are included as fixed effects in the model. Patients are asked 10 questions (a scale developed by our team), and each questions is scored as correct/incorrect, and percentage of correctly answered questions is calculated (0-100 with 100 as best). Results are presented as adjusted least square means with 95% Confidence Intervals

次要结局

  • Probability of Prescription Medication Proper Use(1 Month post baseline to 3 Months post baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael S. Wolf

Associate Division Chief - Research Division of General Internal Medicine

Northwestern University

研究点 (2)

Loading locations...

相似试验